Flexion Therapeutics Inc Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Flexion Therapeutics Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Flexion Therapeutics Inc for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 8,868,393 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Novo A/S | 10% Owner | Buy | P | 13.00 | 692,308 | 9,000,004 | 1,783,131 | 1.1 M to 1.8 M (+63.47 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 1,090,823 | 0 | 1,090,823 | 0 to 1.1 M |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Tordjman Rafael | Director | Option Exercise | C | 0.00 | 2,116,562 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Tordjman Rafael | Director | Option Exercise | C | 0.00 | 13,124,932 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Tordjman Rafael | Director | Buy | P | 13.00 | 230,769 | 2,999,997 | 2,105,491 | 1.9 M to 2.1 M (+12.31 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Tordjman Rafael | Director | Buy | C | 0.00 | 260,340 | 0 | 1,874,722 | 1.6 M to 1.9 M (+16.13 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Tordjman Rafael | Director | Buy | C | 0.00 | 1,614,382 | 0 | 1,614,382 | 0 to 1.6 M |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 18,512 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 3,135,165 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 2,900,000 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 97,797 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 16,558,351 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | 10% Owner | Buy | P | 13.00 | 1,806 | 23,478 | 3,206,807 | 3.2 M to 3.2 M (+0.06 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | 10% Owner | Buy | P | 13.00 | 305,886 | 3,976,518 | 3,205,001 | 2.9 M to 3.2 M (+10.55 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 2,277 | 0 | 2,899,115 | 2.9 M to 2.9 M (+0.08 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 385,629 | 0 | 2,896,838 | 2.5 M to 2.9 M (+15.36 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 356,703 | 0 | 2,511,209 | 2.2 M to 2.5 M (+16.56 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 12,029 | 0 | 2,122,526 | 2.1 M to 2.1 M (+0.57 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 2,036,697 | 0 | 2,110,064 | 73.4 K to 2.1 M (+2,776.04 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Sofinnova Partners SAS | 10% Owner | Option Exercise | C | 0.00 | 2,116,562 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Sofinnova Partners SAS | 10% Owner | Option Exercise | C | 0.00 | 13,124,932 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Sofinnova Partners SAS | 10% Owner | Buy | P | 13.00 | 230,769 | 2,999,997 | 2,105,491 | 1.9 M to 2.1 M (+12.31 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Sofinnova Partners SAS | 10% Owner | Buy | C | 0.00 | 260,340 | 0 | 1,874,722 | 1.6 M to 1.9 M (+16.13 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Sofinnova Partners SAS | 10% Owner | Buy | C | 0.00 | 1,614,382 | 0 | 1,614,382 | 0 to 1.6 M |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Schwab Andrew J. | Director | Option Exercise | C | 0.00 | 1,693,249 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Schwab Andrew J. | Director | Option Exercise | C | 0.00 | 10,499,946 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Schwab Andrew J. | Director | Buy | C | 0.00 | 208,272 | 0 | 1,512,076 | 1.3 M to 1.5 M (+15.97 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Schwab Andrew J. | Director | Buy | C | 0.00 | 1,291,505 | 0 | 1,303,804 | 12.3 K to 1.3 M (+10,500.89 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | PFIZER INC | 10% Owner | Option Exercise | C | 0.00 | 1,904,905 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | PFIZER INC | 10% Owner | Option Exercise | C | 0.00 | 11,812,438 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | PFIZER INC | 10% Owner | Buy | C | 0.00 | 234,306 | 0 | 1,687,250 | 1.5 M to 1.7 M (+16.13 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | PFIZER INC | 10% Owner | Buy | C | 0.00 | 1,452,944 | 0 | 1,452,944 | 0 to 1.5 M |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Option Exercise | C | 0.00 | 3,153,677 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Option Exercise | C | 0.00 | 19,556,148 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 13.00 | 307,692 | 3,999,996 | 3,206,807 | 2.9 M to 3.2 M (+10.61 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | C | 0.00 | 387,906 | 0 | 2,899,115 | 2.5 M to 2.9 M (+15.45 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | C | 0.00 | 2,405,429 | 0 | 2,511,209 | 105.8 K to 2.5 M (+2,273.99 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Option Exercise | C | 0.00 | 2,900,000 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | C | 0.00 | 356,703 | 0 | 388,683 | 32 K to 388.7 K (+1,115.39 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 3,153,677 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 19,556,148 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Bolzon Bradley J PhD | Director | Buy | P | 13.00 | 307,692 | 3,999,996 | 3,206,807 | 2.9 M to 3.2 M (+10.61 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 387,906 | 0 | 2,899,115 | 2.5 M to 2.9 M (+15.45 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 2,405,429 | 0 | 2,511,209 | 105.8 K to 2.5 M (+2,273.99 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Option Exercise | C | 0.00 | 2,900,000 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Medical Offic ... | Buy | C | 0.00 | 356,703 | 0 | 388,683 | 32 K to 388.7 K (+1,115.39 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | 5AM Ventures II LP | 10% Owner | Option Exercise | C | 0.00 | 1,693,249 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | 5AM Ventures II LP | 10% Owner | Option Exercise | C | 0.00 | 10,499,946 | 0 | 0 | |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | 5AM Ventures II LP | 10% Owner | Buy | C | 0.00 | 208,272 | 0 | 1,512,076 | 1.3 M to 1.5 M (+15.97 %) |
| Feb 20 2014 | FLXN | Flexion Therapeuti ... | 5AM Ventures II LP | 10% Owner | Buy | C | 0.00 | 1,291,505 | 0 | 1,303,804 | 12.3 K to 1.3 M (+10,500.89 %) |